Tao Guo

机构：South China Agricultural University, Jiangsu University, University of Science and Technology of China, Nanjing University of Chinese Medicine, Anhui Medical University, Wuhan University, Myocardial Solutions (United States), Affiliated Hospital of Jiangsu University, Zhongnan Hospital of Wuhan University, First Affiliated Hospital of Anhui Medical University, Guizhou Provincial People's Hospital, Huazhong University of Science and Technology, Taiyuan University of Technology · ORCID：0000-0002-7340-3762

发表论文 304 篇 · 总被引 9620 次 · h-index 39

代表论文

• The effects of aquaporin-4 polymorphisms on glymphatic function and motor symptoms in Parkinson’s disease (2025 · npj Parkinson s Disease · 被引 7)
• Glymphatic dysfunction is related to motor disability fully mediated by gray matter degeneration in early-stage Parkinson's disease (2025 · Neurobiology of Disease · 被引 6)
• Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay (2025 · ACS Nano · 被引 5)
• Unlocking the potential of TIGIT in enhancing therapeutic strategies for acute myeloid leukemia through combined azacitidine therapy (2025 · npj Precision Oncology · 被引 4)
• Exogenous mitochondrial transfer alleviates neurodegeneration in Parkinson’s disease model by improving mitochondrial function (2026 · Mitochondrion · 被引 3)
• Aptamer-functionalized nanoparticles for CRISPR-Cas9 delivery to circulating malignant cells for therapeutic efficacy evaluation (2025 · Journal of Controlled Release · 被引 2)